PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'The School of Medicine, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, UK.\', \'Department of Diabetes and Endocrinology, Salford Royal Hospital, Salford, UK.\', \'Res Consortium, Andover, UK.\', \'Vernova Healthcare, Watersgreen Medical Centre, Macclesfield, UK.\', \'Oxford Centre for Diabetes, Endocrinology and Metabolism and NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS FT, Oxford, UK.\', \'Department of Clinical & Experimental Medicine, University of Surrey, Guildford, UK.\', \'University of the West Indies, Cavehill Campus, Bridgetown, Barbados.\', \'Division of Cardiovascular Sciences, Faculty of Biology Medicine and Health, University of Manchester, Manchester, UK.\', \'Faculty of Science and Engineering, Manchester Metropolitan University, Manchester, UK.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1111/dme.14774
?:doi
?:hasPublicationType
?:journal
  • Diabetic medicine : a journal of the British Diabetic Association
is ?:pmid of
?:pmid
?:pmid
  • 34936128
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • The change in glycaemic control immediately after COVID-19 vaccination in people with type 1 diabetes.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all